Equity Details
Price & Market Data
Price: $1.40
Daily Change: +$0.03 / 2.14%
Daily Range: $1.38 - $1.45
Market Cap: $68,909,744
Daily Volume: 10,434
About MediciNova, Inc. (MNOV)
Understand MediciNova, Inc. (MNOV)'s current market standing. Current price: 1.40, daily change: +$0.03 / 2.14%. Market cap: 68,909,744. Detailed performance for all periods.
Company Details
Employees: 6
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, and glioblastoma, as well as prevention of acute respiratory distress syndrome. The company is also developing MN-001 (tipelukast), an orally bioavailable small molecule compound in Phase 2 clinical trial to treat fibrotic and other metabolic disorders, including nonalcoholic fatty liver disease and hypertriglycedemia. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.
